cbdMD Inc (AMEX:YCBD) currently has a daily average trading volume of 1.38M but it saw 3165191 shares traded in last market. With a market cap of 3.76M USD, the company’s current market price of $0.60 came rising about 21.56 while comparing to the previous closing price of $0.49. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.34 and as low as $0.31. In the recent trading on the day, stock has struck highest price mark of $0.49 while lowest mark touched by it was $0.619.
Taking a look at 20-day trading activity of cbdMD Inc (YCBD) gives us an average price of $0.4734, while its current price level is -55.22% below from 52-week high level whereas it is 92.86% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.4595 while that of 200 days or SMA-200 reads an average of $0.5786. A closer look into the stock’s movement over the week reveals that its volatility is standing at 20.33% during that period while stretching the period over a month that increases to 22.11%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 61.45 which implies that the stock is in neutral territory.
Over the week, YCBD’s stock price is moving 18.51% up while it is 62.16% when we observe its performance for the past one month. Year-to-date it is 60.00% up and over the past year, the stock is showing a downside performance of -19.86%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0. Moreover, analysts are in estimates of $5.19M for current-quarter revenue.
Currently, cbdMD Inc’s total number of outstanding shares is 6.26M with 16.11% of that held by the insiders while 3.33% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -392.38% and return on equity (ROE) at -67.31%. Stock’s beta reads 2.04. Stock has a price to book (P/B) ratio of 1.21 while price to sale or P/S ratio amounts to 0.19. Its return on asset (ROA) is -27.64% on average.
